Oculis Labs

Oculis Labs

Company

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

January 2019
Oculis Labs raises a $15,200,000 series B round from Nan Fung Life Sciences and Tekla Capital Management.
January 2018
Oculis Labs raises a $20,300,000 series B round from Silfurberg, Pivotal bioVenture Partners, Brunnur Ventures, Novartis Venture Fund and Bay City Capital.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Oculis funding round, January 2018
20,300,000
January 2018
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Ben Littauer

Investor

Brendan McKernan

Investor

Carter McJunkin

Investor

David Krauskopf

Investor

David Troy

Investor

Greg Cangialosi

Investor

Matt Koll

Investor

Matthew Harrell

Investor

Paul Silber

Investor

Phil Harrell

Investor

Rocky Mehta

Investor

Roger London

Investor

Stephen Andress

Investor

Tom Loveland

Investor

Tommy White

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.